Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone's effects on COVID-19 are unclear and need more research.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Redefining drug dosages is crucial when repurposing them for new uses.